Evidence map›Paper›PMID 30630477›Full record

ArticleBMC complementary and alternative medicine2019

Coreopsis tinctoria Nutt ameliorates high glucose-induced renal fibrosis and inflammation via the TGF-β1/SMADS/AMPK/NF-κB pathways.

Lan Yao, Jie Li, Linlin Li, Xinxia Li, Rui Zhang, Yujie Zhang, Xinmin Mao

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. AI-Integrated Multi-Target Validation ofFoods (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Fast Screening of Tyrosinase Inhibitors inMolecules (Basel, Switzerland) · 2024
    Article
  5. Article
  6. OptimizingAnti-cancer agents in medicinal chemistry · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Vascular Protective Effects ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. Review
  14. The Neuroprotective Effects ofFrontiers in pharmacology · 2021
    Article
  15. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  16. Article
  17. Cilostazol ameliorates diabetic nephropathy by inhibiting highglucose- induced apoptosis.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2020
    Article
  18. Article
  19. Frontiers in bioengineering and biotechnology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lan YaoCollege of Traditional Chinese Medicine, Xinjiang Medical University, No. 4 Liyushan Park, Urumuqi, 830011, China.
Jie LiCollege of Traditional Chinese Medicine, Xinjiang Medical University, No. 4 Liyushan Park, Urumuqi, 830011, China.
Linlin LiCollege of Basic Medicine, Xinjiang Medical University, No. 393 Xinyi Street, Urumuqi, 830011, China.
Xinxia LiCenter of Analysis and Test, Xinjiang Medical University, No. 393 Xinyi Street, Urumuqi, 830011, China.
Rui ZhangCollege of Basic Medicine, Xinjiang Medical University, No. 393 Xinyi Street, Urumuqi, 830011, China.
Yujie ZhangCollege of Traditional Chinese Medicine, Xinjiang Medical University, No. 4 Liyushan Park, Urumuqi, 830011, China.
Xinmin MaoCollege of Traditional Chinese Medicine, Xinjiang Medical University, No. 4 Liyushan Park, Urumuqi, 830011, China. mxm3277@139.com.ORCID http://orcid.org/0000-0001-6840-3357
Xinjiang Medical University · CNTianjin University of Traditional Chinese Medicine · CN

Funding

Natural Science Foundation of China 81560671Natural Science Foundation of China U1303223
6 · The paper itself

Abstract

backgroundCoreopsis tinctoria Nutt is an ethnomedicine widely used in Xinjiang, China. It is consumed as a herbal tea by local Uyghur people to treat high blood pressure and diarrhea. Our previous study confirmed that the ethyl acetate extract of Coreopsis tinctoria (AC) had a protective effect on diabetic nephropathy (DN) in an in vivo experiment. Here we aim to elucidate the protective mechanism of AC and marein, the main ingredient in Coreopsis tinctoria on renal fibrosis and inflammation in vitro under high glucose (HG) conditions.

methodsA HG-induced barrier dysfunction model in rat mesangial cells (HBZY-1) was established. The cells were exposed to AC and marein and/or HG for 24 h. Then, the renal protective effects of AC and marein via transforming growth factor-β1 (TGF-β1)/Smads, AMP-activated kinase protein (AMPK), and nuclear factor kappa beta (NF-κB) signaling were assessed.

resultsBoth AC and marein suppressed rat mesangial cell hyperplasia and significantly attenuated the expression of HG-disrupted fibrotic and inflammatory proteins in HBZY-1 cells. It was also confirmed that AC and marein remarkably attenuated HG-induced renal inflammation and fibrosis by regulating the AMPK, TGF-β1/Smads, and NF-κB signaling pathways.

conclusionThese results indicated that AC and marein may delay the progression of DN, at least in part, by suppressing HG-induced renal inflammation and fibrosis. Marein may be one of the bioactive compounds in AC.

Indexed as

AMP-Activated Protein Kinase KinasesAnimalsChalconesCoreopsisDrugs, Chinese HerbalFibrosisGlucoseHumansKidney DiseasesMesangial CellsNF-kappa BProtein KinasesRatsSignal TransductionSmad ProteinsTransforming Growth Factor beta1AMP-Activated Protein Kinase KinasesChalconesDrugs, Chinese HerbalGlucosemareinNF-kappa BProtein KinasesSmad ProteinsTransforming Growth Factor beta1Anti-fibrosis and anti-inflammationEthyl acetate extract of Coreopsis tinctoriaHigh glucose-treated mesangial cellsMechanism

Identifiers

PMID30630477
PMCPMC6327481
OpenAlexW2912396270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.